NASDAQ: SILOSilo Pharma Inc Stock Ownership - Who owns Silo Pharma?
Insider buying vs selling
Have Silo Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Eric Weisblum | Chief Executive Officer | 2025-05-27 | 10,000 | $0.43 | $4.33kBuy |
| Eric Weisblum | CEO and President | 2024-12-13 | 2,500 | $0.84 | $2.10kBuy |
| Eric Weisblum | CEO and President | 2024-11-22 | 2,500 | $0.90 | $2.25kBuy |
| Eric Weisblum | CEO and President | 2024-11-20 | 2,500 | $0.95 | $2.38kBuy |
SILO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SILO insiders and whales buy or sell their stock.
SILO Shareholders
What type of owners hold Silo Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Eric Weisblum | 4.41% | 197,932 | $118.36k | Insider |
| Advisorshares Investments LLC | 2.77% | 124,236 | $74.29k | Institution |
| Geode Capital Management LLC | 0.99% | 44,487 | $26.60k | Institution |
| Citadel Advisors LLC | 0.46% | 20,689 | $12.37k | Institution |
| Conning Inc | 0.45% | 20,000 | $11.96k | Institution |
| Vanguard Group Inc | 0.36% | 16,334 | $9.77k | Institution |
| State Street Corp | 0.28% | 12,500 | $7.48k | Institution |
| Federation Des Caisses Desjardins Du Quebec | 0.13% | 6,000 | $3.59k | Institution |
| Daniel E. Ryweck | 0.11% | 5,000 | $2.99k | Insider |
| Citigroup Inc | 0.03% | 1,532 | $916.14 | Institution |
SILO vs Biotech Stocks
Silo Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.